PHARMACIE SAYDE-DELION SARL : revenue, balance sheet and financial ratios

PHARMACIE SAYDE-DELION SARL is a French company founded 53 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in PUISEAUX (45390), this company of category PME shows in 2023 a revenue of 2.3 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - PHARMACIE SAYDE-DELION SARL (SIREN 087380564)
Indicator 2024 2023 2022 2021 2020 2019 2018 2017
Revenue N/C 2 308 517 € N/C 2 374 444 € 2 230 301 € 2 128 242 € 2 123 009 € 2 273 816 €
Net income 303 492 € 345 973 € 403 240 € 359 314 € 359 638 € 322 680 € 344 107 € 462 875 €
EBITDA N/C 348 762 € N/C 362 114 € 340 936 € 287 586 € 357 581 € 478 767 €
Net margin N/C 15.0% N/C 15.1% 16.1% 15.2% 16.2% 20.4%

Revenue and income statement

In 2024, PHARMACIE SAYDE-DELION SARL generates positive net income of 303 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2017-2024: 463 k€ -> 303 k€.

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

303 492 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 279%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 21%. The balance between equity and debt is satisfactory.

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

278.753%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

21.275%

Asset age ratio (2024) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

1.6%

Solvency indicators evolution
PHARMACIE SAYDE-DELION SARL

Sector positioning

Debt ratio
278.75 2024
2022
2023
2024
Q1: 16.46
Med: 58.47
Q3: 154.89
Average

In 2024, the debt ratio of PHARMACIE SAYDE-DELION SARL (278.75) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
21.27% 2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Watch

In 2024, the financial autonomy of PHARMACIE SAYDE-DELION SARL (21.3%) ranks in the bottom 25% of the sector. This ratio represents the share of equity in total financing. Low autonomy may limit investment capacity and increase vulnerability.

Repayment capacity
2.49 years 2023
2023
Q1: 0.95 years
Med: 3.59 years
Q3: 7.48 years
Good

In 2023, the repayment capacity of PHARMACIE SAYDE-DELION SARL (2.49) ranks below the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. This controlled position reflects prudent management.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 234.93. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2024) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

234.933

Liquidity indicators evolution
PHARMACIE SAYDE-DELION SARL

Sector positioning

Liquidity ratio
234.93 2024
2022
2023
2024
Q1: 129.47
Med: 182.13
Q3: 260.78
Good +9 pts over 3 years

In 2024, the liquidity ratio of PHARMACIE SAYDE-DELION SARL (234.93) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.

Interest coverage
0.95x 2023
2023
Q1: 0.38x
Med: 2.71x
Q3: 6.47x
Average

In 2023, the interest coverage of PHARMACIE SAYDE-DELION SARL (0.9x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.

Operating WCR (2024) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2024) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2024) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

0 j

Inventory turnover (2024) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
PHARMACIE SAYDE-DELION SARL

Positioning of PHARMACIE SAYDE-DELION SARL in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 225 transactions of similar company sales in 2024, the value of PHARMACIE SAYDE-DELION SARL is estimated at 4 236 972 € (range 2 950 560€ - 6 338 753€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2024
225 transactions
2950k€ 4236k€ 6338k€
4 236 972 € Range: 2 950 560€ - 6 338 753€
NAF 5 année 2024

Valuation method used

Net Income Multiple
303 492 € × 14.0x = 4 236 973 €
Range: 2 950 561€ - 6 338 754€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare PHARMACIE SAYDE-DELION SARL with other companies in the same sector:

Frequently asked questions about PHARMACIE SAYDE-DELION SARL

What is the revenue of PHARMACIE SAYDE-DELION SARL ?

The revenue of PHARMACIE SAYDE-DELION SARL in 2023 is 2.3 M€.

Is PHARMACIE SAYDE-DELION SARL profitable?

Yes, PHARMACIE SAYDE-DELION SARL generated a net profit of 303 k€ in 2024.

Where is the headquarters of PHARMACIE SAYDE-DELION SARL ?

The headquarters of PHARMACIE SAYDE-DELION SARL is located in PUISEAUX (45390), in the department Loiret.

Where to find the tax return of PHARMACIE SAYDE-DELION SARL ?

The tax return of PHARMACIE SAYDE-DELION SARL is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does PHARMACIE SAYDE-DELION SARL operate?

PHARMACIE SAYDE-DELION SARL operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.